Ozempic may be reshaping the brain, scientists say
Researchers found the pills also reduced dopamine signaling in a brain reward circuit, pointing to possible uses beyond weight loss.
- A new NIH-funded study published in Nature on May 6 reveals that oral GLP-1 weight-loss drugs target a deep-brain reward circuit, dampening 'hedonic feeding'—eating motivated by pleasure rather than hunger.
- Researchers found these oral compounds activate the central amygdala, a brain region tied to desire and reward that scientists previously did not believe GLP-1 drugs could directly access, reducing dopamine release during pleasure-driven eating.
- Investigating small-molecule drugs including orforglipron and danuglipron, the team mapped activated brain regions in mice; scientists are now planning to determine if these newer medications can also reduce cravings unrelated to food.
- "Now it seems oral small-molecule GLP-1s also dial back eating for pleasure by engaging a brain reward circuit," said co-corresponding author Ali Guler, suggesting potential for treating addiction.
- Future studies will examine the drugs' potential effects on substance use disorder; as medication accessibility rises, experts emphasize understanding the neural mechanisms underlying these complex behavioral effects.
9 Articles
9 Articles
Another effect of weight loss drugs could be changing the brain, research suggests
Scientists are looking to see how GLP-1 drugs may impact the brain and reshape people’s nervous systems
Ozempic And Other GLP-1 Drugs May Be Altering The Brain, researchers say
Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while studying adolescents and young women taking GLP-1 medications for a hormonal
Scientists Identify Hidden Brain Pathway Behind GLP-1 Weight-Loss Effects
A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyond weight loss. Why do GLP-1 weight-loss drugs seem to quiet cravings in ways that go beyond simple appetite suppression? A new NIH-funded study suggests the answer may lie deep within the [...]
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium








